FTC IDs 300+ 'Junk Patents' Among Drugmakers
The Federal Trade Commission on Tuesday challenged the legitimacy of more than 300 "junk patents" for drugs treating a range of conditions from diabetes to COPD and including Novo Nordisk Inc.'s weight-loss drug Ozempic. In warning letters to …